Estimating cancer prevalence using mixture models for cancer survival.
Knowledge of cancer prevalence is useful for estimating the ongoing level of resources utilized in the treatment of disease and is of some public health interest. Cancer prevalence is estimated first as the proportion of persons previously diagnosed (PD) with cancer that are still alive; and second as the proportion of individuals in the population who were previously diagnosed with cancer and who have not been cured (NC). The proportion of cases that are cured is estimated by assuming that the cured and uncured cases have distinct survival patterns. The hazard for cured cases is assumed to be a multiple of the hazard from causes other than cancer in the general population. The hazard for uncured cases is assumed to have two independent components: one corresponding to the disease-specific hazard, and the other a multiple of the population hazard from 'other causes'. Future prevalence estimates are obtained by projecting the survival of current prevalent cases as well as the survival of future incident cases.
Phillips
Norman
N
Cancer Control Research, BC Cancer Agency, Suite 801, 686 W. Broadway, Vancouver, BC, V5Z 1G1, Canada.
Coldman
Andrew
A
McBride
Mary L
ML
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001955:British Columbia / Q000453:epidemiology; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009369:Neoplasms / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies